---
category: news
title: "CytoReason Collaborates with Sanofi, Using its AI Technology to Gain Better Understanding of Disease Mechanisms"
excerpt: "CytoReason, an AI company developing a computational disease model of the human body for clinical drug development, today announced the initiation of a project with French global biopharmaceutical company Sanofi,"
publishedDateTime: 2021-06-17T13:49:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/cytoreason-collaborates-with-sanofi-using-its-ai-technology-to-gain-better-understanding-of-disease-mechanisms-1030532479"
webUrl: "https://markets.businessinsider.com/news/stocks/cytoreason-collaborates-with-sanofi-using-its-ai-technology-to-gain-better-understanding-of-disease-mechanisms-1030532479"
type: article
quality: 47
heat: 47
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1513066/CytoReason_Logo.jpg"
    width: 400
    height: 256
    isCached: true

secured: "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;mB4k7AX2aua7YZp0ARqzCQ=="
---

